Ensysce Biosciences

1 follower


Ensysce Biosciences, Inc. (Ensysce) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.

Industries

Headquarters

Stage

Employees

Links

Org chart

D. Lynn Kirkpatrick

Collapse
Dave Humphrey
Chief Financial Officer
Geoff Birkett
Chief Commercial Officer
Linda Pestano
Chief Development Officer
William Schmidt
Chief Medical Officer.
Steve Martin
Board Member